Pzena Investment Management LLC Buys Shares of 1,157,273 Envista Holdings Corporation $NVST

Pzena Investment Management LLC purchased a new position in shares of Envista Holdings Corporation (NYSE:NVST) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 1,157,273 shares of the company’s stock, valued at approximately $30,494,000.

Several other hedge funds and other institutional investors have also modified their holdings of NVST. Dimensional Fund Advisors LP boosted its holdings in Envista by 1.6% during the 1st quarter. Dimensional Fund Advisors LP now owns 9,780,948 shares of the company’s stock valued at $248,130,000 after acquiring an additional 152,488 shares during the period. Alliancebernstein L.P. boosted its stake in shares of Envista by 34.0% in the second quarter. Alliancebernstein L.P. now owns 6,098,445 shares of the company’s stock valued at $119,164,000 after purchasing an additional 1,547,656 shares during the period. Arrowstreet Capital Limited Partnership boosted its stake in shares of Envista by 341.5% in the first quarter. Arrowstreet Capital Limited Partnership now owns 2,858,293 shares of the company’s stock valued at $72,515,000 after purchasing an additional 2,210,847 shares during the period. Quantinno Capital Management LP grew its holdings in shares of Envista by 38.8% in the first quarter. Quantinno Capital Management LP now owns 2,694,970 shares of the company’s stock valued at $68,371,000 after purchasing an additional 753,474 shares in the last quarter. Finally, Millennium Management LLC increased its stake in Envista by 1,442.7% during the 4th quarter. Millennium Management LLC now owns 2,420,615 shares of the company’s stock worth $52,552,000 after buying an additional 2,263,712 shares during the period.

Envista Stock Down 1.4%

Shares of NYSE:NVST opened at $27.68 on Tuesday. The firm’s 50 day moving average price is $26.66 and its 200 day moving average price is $26.19. The stock has a market cap of $4.45 billion, a price-to-earnings ratio of 47.72, a price-to-earnings-growth ratio of 1.34 and a beta of 0.86. Envista Holdings Corporation has a fifty-two week low of $18.77 and a fifty-two week high of $30.42. The company has a quick ratio of 2.07, a current ratio of 2.43 and a debt-to-equity ratio of 0.47.

Envista (NYSE:NVST) last issued its quarterly earnings results on Wednesday, August 5th. The company reported $0.41 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.34 by $0.07. Envista had a net margin of 3.33% and a return on equity of 7.88%. The company had revenue of $730.50 million during the quarter, compared to the consensus estimate of $716.11 million. During the same quarter in the previous year, the firm earned $0.26 earnings per share. The firm’s quarterly revenue was up 7.1% on a year-over-year basis. Envista has set its FY 2026 guidance at 1.500-1.550 EPS. As a group, equities research analysts predict that Envista Holdings Corporation will post 1.53 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

NVST has been the topic of a number of research reports. Weiss Ratings upgraded shares of Envista from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, August 6th. Evercore restated an “outperform” rating and issued a $33.00 price target on shares of Envista in a research note on Thursday, May 7th. Piper Sandler reaffirmed a “neutral” rating and set a $28.00 price objective (up from $26.00) on shares of Envista in a research report on Thursday, August 6th. JPMorgan Chase & Co. increased their price objective on Envista from $26.00 to $29.00 and gave the company a “neutral” rating in a research note on Thursday, May 7th. Finally, Mizuho set a $29.00 target price on Envista in a report on Thursday, August 6th. One investment analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and nine have assigned a Hold rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $29.31.

Envista Profile

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.